ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,228.40
0.00%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.3681
-0.08%
Bitcoin
69,474.84
0.54%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Progen Industries (PGLAF)

  7. Progen Industries (PGLAF) News

PGLAF

Progen (PGLAF)

Progen Industries
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PGLAF
DateTimeSourceHeadlineSymbolCompany
05/16/20065:53AMPR Newswire (US)Progen Prepares for Accelerated Clinical Development of PI-88 Following FDA MeetingNASDAQ:PGLAFProgen Industries
08/09/20056:00AMPR Newswire (US)Progen Expand PI-88 Clinical Development to Prostate CancerNASDAQ:PGLAF
06/28/200512:28AMPR Newswire (US)Progen Engages Burrill to Advance PI-88 Partnering DiscussionsNASDAQ:PGLAF
05/16/200511:14PMPR Newswire (US)Results of PI-88 Phase II Clinical Trial in Melanoma Presented at ASCONASDAQ:PGLAFProgen Industries
08/26/200411:53PMPR Newswire (US)Progen Reports Solid Financial PerformanceNASDAQ:PGLAFProgen Industries
07/13/200410:36PMPR Newswire (US)PI-88 Phase II Clinical Trial Targeting Liver Cancer LaunchedNASDAQ:PGLAFProgen Industries
05/03/20049:49PMPR Newswire (US)U.S. FDA Grants Orphan Drug Status to PI-88 for MelanomaNASDAQ:PGLAF
02/27/20045:00AMPR Newswire (US)Half Year Report - Progen on Track to Meet MilestonesNASDAQ:PGLAF
02/10/200410:48PMPR Newswire (US)Progen Commences Third PI-88 Phase II TrialNASDAQ:PGLAFProgen Industries
11/18/20039:20PMPR Newswire (US)Bonus Issue of Options - Record Date November 28 2003NASDAQ:PGLAFProgen Industries
11/10/20037:58PMPR Newswire (US)Progen Sharpens Cancer Focus Through DivestmentNASDAQ:PGLAF
10/31/200312:43AMPR Newswire (US)Progen Industries Limited New Placement Terms AnnouncedNASDAQ:PGLAFProgen Industries
10/31/200312:30AMPR Newswire (US)Progen Industries Limited Annual General MeetingNASDAQ:PGLAF
10/28/20037:42PMPR Newswire (US)Progen Granted Anti-Angiogenesis Antibody PatentNASDAQ:PGLAFProgen Industries
 Showing the most relevant articles for your search:NASDAQ:PGLAF

Your Recent History

NASDAQ
NVDA
NVIDIA
USOTC
RDGL
Vivos (QB)
USOTC
ENZC
Enzolytics (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
DPLS
DarkPulse (PK)
AMEX
SPY
SPDR S&P 500
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
RVNC
Revance Therapeutics
USOTC
SONGD
Music Licensing (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
BLEG
Branded Legacy (PK)
USOTC
AXXA
Exxe (PK)
NASDAQ
FCEL
FuelCell Energy
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved